This provides further evidence for DUX4 as the central player in the FSHD disease mechanism and demonstrates that the higher expression of FRG2 in FSHD does not result from regional de-repression secondary to fewer D4Z4 repeats. The gene discussed is FRG2; the disease is facioscapulohumeral muscular dystrophy.